SP100 抗体
(SP100 Nuclear Antigen (SP100))
This gene encodes a subnuclear organelle and major component of the PML (promyelocytic leukemia)-SP100 nuclear bodies. PML and SP100 are covalently modified by the SUMO-1 modifier, which is considered crucial to nuclear body interactions. The encoded protein binds heterochromatin proteins and is thought to play a role in tumorigenesis, immunity, and gene regulation. Alternatively spliced variants have been identified for this gene\; one of which encodes a high-mobility group protein. [provided by RefSeq, Aug 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SP100 抗体 (AA 610-802) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 1-98) | 人 | 小鼠 Monoclonal |
|
|
|
| SP100 抗体 (AA 1-480) | 人 | 小鼠 Polyclonal |
|
|
|
| SP100 抗体 (AA 1-480) | 人 | 小鼠 Polyclonal |
|
|
|
| SP100 抗体 (AA 1-480) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 181-480) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 1-98) | 人 | 小鼠 Polyclonal |
|
|
|
| SP100 抗体 (AA 116-333) | 大鼠 | 兔 Polyclonal |
|
|
|
| SP100 抗体 | 小鼠 | 兔 Polyclonal |
|
|
|
| SP100 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| SP100 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| SP100 抗体 (AA 250-330) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 199-227) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 199-227) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 199-227) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 199-227) (PE) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 199-227) (APC) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 610-802) | 人 | 兔 Polyclonal |
|
|
|
| SP100 抗体 (AA 1-480) | 人, 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 610-802
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- RNAi (RNA Interference: 所列应用)
1 reference - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1G6
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 1-98
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-480
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-480
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-480
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 181-480
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-98
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 116-333
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- PCRP-SP100-1B9
- 标记
- unconjugated
- 抗体亚型
- IgG2b
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 250-330
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 199-227
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 199-227
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 199-227
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 199-227
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 199-227
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 610-802
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-480
Latest Publications for our SP100 抗体
: "The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection." in: PLoS ONE, Vol. 12, Issue 1, pp. e0169648, (2017) (PubMed).
: "Quantification of the host response proteome after herpes simplex virus type 1 infection." in: Journal of proteome research, Vol. 14, Issue 5, pp. 2121-42, (2015) (PubMed).
: "Contribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1." in: Viruses, Vol. 7, Issue 6, pp. 2884-907, (2015) (PubMed).
: "Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity." in: PLoS pathogens, Vol. 10, Issue 1, pp. e1003863, (2014) (PubMed).
: "Sp100 provides intrinsic immunity against human papillomavirus infection." in: mBio, Vol. 4, Issue 6, pp. e00845-13, (2013) (PubMed).
: "Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100." in: The Journal of general virology, Vol. 92, Issue Pt 7, pp. 1532-8, (2011) (PubMed).
: "Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle." in: Journal of virology, Vol. 85, Issue 18, pp. 9447-58, (2011) (PubMed).
: "Quantification of the host response proteome after herpes simplex virus type 1 infection." in: Journal of proteome research, Vol. 14, Issue 5, pp. 2121-42, (2015) (PubMed).
: "Contribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1." in: Viruses, Vol. 7, Issue 6, pp. 2884-907, (2015) (PubMed).
: "Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity." in: PLoS pathogens, Vol. 10, Issue 1, pp. e1003863, (2014) (PubMed).
: "Sp100 provides intrinsic immunity against human papillomavirus infection." in: mBio, Vol. 4, Issue 6, pp. e00845-13, (2013) (PubMed).
: "Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100." in: The Journal of general virology, Vol. 92, Issue Pt 7, pp. 1532-8, (2011) (PubMed).
: "Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle." in: Journal of virology, Vol. 85, Issue 18, pp. 9447-58, (2011) (PubMed).
Aliases for SP100 抗体
SP100 nuclear antigen (SP100) 抗体nuclear antigen Sp100 (Sp100) 抗体
SP100 nuclear antigen (Sp100) 抗体
nuclear autoantigen Sp-100 (LOC101120993) 抗体
A430075G10Rik 抗体
lysp100b 抗体
SP100 抗体
SP140 抗体
您还需要查找其他产品吗？
You are here:
